Top 10 orthopedic companies by market share — and where they'll be in 2022

Written by Laura Dyrda | April 02, 2018 | Print  |

Johnson & Johnson leads the orthopedic device market with a quarter of the market share; however it's expected to drop around 3 percent over the next five years. Stryker, NuVasive and Globus Medical are expected to have slight gains over that time period while others leaders are also expected to drop.

Here is the breakdown for 2016 market share and predictions for 2022, according to Statista.

1. Johnson & Johnson had 25.1 percent market share in 2016 and is expected to have 22.8 percent in 2022.

2. Zimmer Biomet had 20.7 percent market share in 2016 and is expected to have 19.8 percent in 2022.

3. Stryker had 16.1 percent market share in 2016 and is expected to have 17.1 percent in 2022.

4. Medtronic had 7.9 percent market share in 2016 and is expected to have 8.4 percent in 2022.

5. Smith & Nephew had 5.7 percent market share in 2016 and is expected to have 5.5 percent in 2022.

6. Arthrex had 4.9 percent market share in 2016 and is expected to have the same, 4.9 percent, in 2022.

7. NuVasive had 2.5 percent market share in 2016 and is expected to have 2.9 percent in 2022.

8. Wright Medical Group had 2 percent market share in 2016 and is expected to have 2.9 percent in 2022.

9. Globus Medical had 1.6 percent market share in 2016 and is expected to have 2 percent in 2022.

10. Orthofix had 1.2 percent market share in 2016 and is expected to have 1.1 percent in 2022.

More articles on orthopedic devices:
K2M names new COO: 5 things to know about Lane Major
Medtronic, J&J, Smith & Nephew & more: 10 device company notes
Medtronic to redeem $1.2B company shares: 4 things to know

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months